Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 13, 2004
(October 13, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new coronary...
-
Oct 6, 2004
(October 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2004 on Tuesday, October 19,...
-
Oct 1, 2004
and Washington, D.C. (October 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting safety from three post-market registries associated with its TAXUS™...
-
Oct 1, 2004
and Washington, D.C. (October 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from its TAXUS V clinical trial. The trial is assessing the slow-release...
-
Sep 29, 2004
and Washington, D.C. (September 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced two-year follow-up data from its TAXUS IV clinical trial. The benefits reported at 12 months...